| 1 |
Dalfampridine
| [4] 4-aminopyridine 4-aminopyridine; Dalfampridine; FAMPRIDINA; FAMPRIDINE | [1] Dalfampridine
Dalfampridine
💬
| [7] KCNA1 KCNA1, KCNA2, KCNA4, KCNA6, KCNC3, KCND2, KCND3 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬 | [2] 4 4, 13 💬
|
| 2 |
Dexmedetomidine
| [4] DEXMEDETOMIDINA DEXMEDETOMIDINA; Dexmedetomidine; DEXMEDETOMIDINE HYDROCHLORIDE; Imidazole | [2] Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [15] 2 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
|
| 3 |
Esketamine
| [3] Esketamine Esketamine; Esketamine hydrochloride; Ketamine | [2] Esketamine
Esketamine
,
Esketamine hydrochloride
💬
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [21] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [7] 2 2, 4, 6, 70, 96, 97, 156 💬
|
| 4 |
Levetiracetam
| [1] Levetiracetam Levetiracetam | [1] Levetiracetam
Levetiracetam
💬
| [1] SV2A SV2A 💬
| [1] ECM-receptor interaction ECM-receptor interaction 💬 | [7] 2 2, 4, 6, 13, 34, 149, 307 💬
|
| 5 |
Pyrimethamine
| [1] PYRIMETHAMINE PYRIMETHAMINE | [1] Pyrimethamine
Pyrimethamine
💬
| - | - | [4] 2 2, 4, 19, 65 💬
|